Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Medical - Devices

Healthcare
$17.05 +1.53%

+$0.24 today

Market cap
$1.19B
Beta
1.57
P/E (TTM)
-11.3
EPS (TTM)
-$1.38
52W Low $9.98High $29.65

Volume 2.35M

Average 2.43M

TNDM Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Tandem Diabetes Care, Inc.NASDAQ: TNDM

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income declines year over year

Q1 FY2026 net income of $20.39M (cash outflow) fell 84.4% year over year, behind the -48.6% change in trailing-twelve-month net income. Sequentially, it rose 3362.3% from the prior quarter. Over 3 fiscal years it compounded at +29.3% a year.

Context

  • Net income amounted to 20.2% of revenue in FY2025, up 10.0 pp from a year earlier.
  • Net income grew in size in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 18 analysts of -$38.81M (-81.0%) for the fiscal year ending Dec 2026, a slowdown from the +113.2% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$20.39M+3362.3% QoQ
Last fiscal yearDec 2025
-$204.71M+113.2% YoY
LTMMar 2026
-$94.55M-48.6% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-84.4%-57.4%+27.0 pp
1 year+113.2%-81.0%-194.2 pp
3-year CAGR+29.3%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(204.71M) USD
Year-over-year change
-113.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How TNDM compares with its peers on the latest reported figures

  • TNDM's LTM Mar 2026 net income of $94.55M is the 5th largest of the 8 companies compared; the peer median is $66.44M.
  • Its year-over-year change of -48.6% is the 6th highest of 7, against a peer median of +19.5%.
  • Net income amounts to 9.2% of revenue for TNDM, versus a peer median of 16.2%.
TNDM Competitors Peer median
Net Income for TNDM and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DXCMDexCom, Inc.LTM Jun 2026$999.7M +74.9%+34.8%20.1%
PODDInsulet CorporationLTM Jun 2026$375.3M +59.0%+277.3%12.3%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026$301M —+51.0%9.3%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$108M +21.2%+44.8%—
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$94.55M -48.6%+29.3%9.2%
SENSSenseonics Holdings, Inc.LTM Mar 2026$87.19M +17.8%—214.2%
BBNXBeta Bionics, Inc.LTM Mar 2026$66.44M -6.4%+4.2%60.3%
MNKDMannKind CorporationLTM Mar 2026$23.91M -179.4%—6.6%
MMEDVMiniMed Group, Inc.—— ———
Peer median (excluding TNDM) $66.44M+19.5%+44.8%16.2%

Competitors are the stored peer set for TNDM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income15.57M(94.59M)(222.61M)(96.03M)(204.71M)
Depreciation & Amortization13.85M14.33M15.72M16.61M13.84M
Deferred Income Tax00000
Stock-Based Compensation60.75M84.92M88.08M101.38M92.38M
Change in Working Capital14.37M(4.65M)(17.69M)(11.78M)(23.04M)
Accounts Receivables(30.98M)(7.83M)4.28M(20.8M)(56.81M)
Inventory(4.95M)(42.45M)(46.05M)5.81M24.82M
Accounts Payables10.28M24.49M(4.86M)(2.39M)2.23M
Other Working Capital40.03M21.14M28.96M5.6M6.73M
Other Non-Cash Items6.82M50.46M104.7M14.04M111.81M
Operating Cash Flow111.36M50.46M(31.81M)24.23M(9.72M)
Capital Expenditures(23.51M)(34.1M)(26.8M)(19.23M)(19.95M)
Acquisitions (Net)0(25.72M)(69.5M)00
Purchases of Investments(733.39M)(467.65M)(535.66M)(264.31M)(85.66M)
Sales of Investments570.02M569.49M546.22M306.46M257.07M
Other Investing Activities(9.33M)(8.86M)0(46.4M)(78.59M)
Investing Cash Flow(186.88M)33.17M(85.74M)(23.48M)72.88M
Debt Repayment00044.91M(40.76M)
Common Stock Issued017.55M0(6.73M)(2.61M)
Common Stock Repurchased000(30M)0
Dividends Paid00000
Other Financing Activities51.93M(675K)4.11M183K0
Financing Cash Flow51.93M16.88M4.11M8.37M(43.37M)
Effect of Forex Changes153K827K(212K)1.26M1.61M
Net Change in Cash(23.43M)101.34M(113.65M)10.37M21.4M
Free Cash Flow87.85M16.37M(58.61M)4.99M(29.67M)

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Intrinsic Alpha fair value

Locked

Current Price

$17.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.